Trial intelligence / Profile preview

Letrozole and Chemotherapy in Metastatic Breast Cancer

NCT00333047Phase 3Completed

Sponsor
Novartis
Start
Jul 2002
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of letrozole in breast cancer, sponsored by Novartis. Started Jul 2002; status: completed.

02

Drugs

letrozole
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00333047.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00333047.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call